Further observations on the spasmogenic activity of caerulein on the rat pylorus.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002108:Ceruletide / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D005755:Gastrins / Q000037:antagonists & inhibitors; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D011708:Pylorus / Q000187:drug effects*; D051381:Rats; D012702:Serotonin Antagonists; D013035:Spasm / Q000139:chemically induced; D013565:Sympatholytics / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D005730:Ganglionic Blockers; D005755:Gastrins; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010455:Peptides; D012702:Serotonin Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics; D001285:Atropine; D002108:Ceruletide